RheumNow Week in Review – 5 August 2016 Save

Highlights from this week on RheumNow.com include:

1. Having #RA in addition to solid cancer (breast, lung, prostate, colon) increases mortality rates by 40-50% in elders https://t.co/aitjusmOai
2. The global market for rheumatoid arthritis therapies was $19.9 billion in 2015, expected to reach $21.3B by 2020 https://t.co/d2Sh5C8y9f
3. Half of doctors never heard of MACRA:Medicare Access & CHIP Reauthorization Act. Starts on Jan 1st! https://t.co/eYgWBWCw6y Blog:https://t.co/sRKZSOFyNV
4. TEAR had significantly improved RA activity assoc w/ increased cholesterol, HDL, LDL w/ MTX, MTX/ETN, triple DMARD https://t.co/97yEXn2qOh
5. Muscle relaxants give short term relief in acute LBP, but unproven for chronic LBP. Benzodiazepines not effective. https://t.co/APYTNB4CIg
6. 643 postmenopausal OP women w/ prior bisphosphonate Rx given zolendronic acid or denosumab;More BMD w/ denosumab@1yr https://t.co/oXAW5p2U43
7. Early RA pts higher fracture risk w/ pred >15mg/d & >6400mg total. Fx risk 29% lower 60-182 d after d/c prednisone https://t.co/D9PCNQhtK4
8. Serious Infections are Not Increased in HIV Patients Treated with TNF Inhibitors. 
9. Dinosaur Arthritis. 
10. Biosimilars are Bioequivalent to Original TNF Inhibitors. 
11. Meniscal Tears May Not Need Surgery.